BlackRock Investment Management’s iRadimed IRMD Stock Holding History

BlackRock Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$164K	Hold	14,741	–	–	﹤0.01%	3242
2016 Q3	$250K	Hold	14,741	–	–	﹤0.01%	3218
2016 Q2	$321K	Buy	14,741 +4,954	+51%	+$89.1K	﹤0.01%	3214
2016 Q1	$188K	Buy	9,787 +152	+2%	+$2.91K	﹤0.01%	3172
2015 Q4	$270K	Buy	9,635 +71	+0.7%	+$2.01K	﹤0.01%	3174
2015 Q3	$233K	Sell	9,564 -80	-0.8%	-$1.91K	﹤0.01%	3223
2015 Q2	$224K	Buy	9,644 +9,235	+2,258%	+$169K	﹤0.01%	3255
2015 Q1	$6K	Hold	409	–	–	﹤0.01%	3805
2014 Q4	$5K	Buy	409 +100	+32%	+$863	﹤0.01%	3910
2014 Q3	$2K	Buy	+309	New	+$2.8K	﹤0.01%	4008

Other funds holding IRMD

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's IRMD Position: Q4 2016 in Review

BlackRock Investment Management held its iRadimed (IRMD) position steady in Q4 2016 at 14,741 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

BlackRock Investment Management first reported a position in IRMD in Q3 2014 and has held it in 10 quarters since. The position peaked at $321K in Q2 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

BlackRock Investment Management held 14,741 shares of iRadimed worth $164K as of Q4 2016.
BlackRock Investment Management left its iRadimed share count unchanged in Q4 2016.
iRadimed made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3242 holding.
BlackRock Investment Management first reported a position in iRadimed in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's iRadimed position peaked at $321K in Q2 2016.
58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.